Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease

• Asıl Yazarlar: V. I. Ignatyeva (Yazar), S. V. Moiseev (Yazar), N. M. Bulanov (Yazar), E. A. Karovajkina (Yazar), A S. Moiseev (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: IRBIS LLC, 2019-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Fabry disease (FD) is a severe lysosome storage disease caused by congenital deficiency of the enzyme α-galactosidase A and characterized by the risk of renal failure combined with cardiovascular and CNS complications. According to the currently available information, the early start of enzyme repla...